ArticleFrontiers in pharmacology2026

Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and in healthy controls.

Qingmei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.